Recursion Pharmaceuticals, Inc. financial statements, including revenue, expenses, and profit

The total revenue of RXRX for the last quarter is 4.55 M USD, and it's 82.57% lower compared to the previous quarter. The net income of Q4 24 is -178.91 M USD.